Ditchcarbon
  • Contact
  1. Organizations
  2. Aldagen, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 8 months ago

Aldagen, Inc. Sustainability Profile

Company website

Aldagen, Inc., a pioneering biotechnology firm headquartered in the United States, is at the forefront of regenerative medicine. Founded in 2007, the company has made significant strides in developing innovative cell therapies, particularly focusing on the unique properties of adult stem cells. With operational regions extending across North America, Aldagen is dedicated to advancing treatments for various degenerative diseases and injuries. The company’s core offerings include proprietary stem cell products that harness the regenerative potential of adult stem cells, setting them apart in the competitive landscape of the biotechnology industry. Aldagen's commitment to scientific excellence and patient-centric solutions has positioned it as a leader in the field, with notable achievements in clinical research and partnerships that enhance its market presence.

DitchCarbon Score

How does Aldagen, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Aldagen, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

32%

Let us know if this data was useful to you

Aldagen, Inc.'s reported carbon emissions

Aldagen, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. This includes a lack of detailed information on Scope 1, 2, or 3 emissions. Furthermore, there are no documented reduction targets or climate pledges available for the company. It is important to note that Aldagen, Inc. is a current subsidiary and may inherit emissions data and climate commitments from its parent organisation. However, no specific details regarding such cascaded data or initiatives from the parent company have been provided. As the company continues to develop its sustainability strategy, stakeholders may look forward to future disclosures that outline its carbon footprint and climate commitments.

How Carbon Intensive is Aldagen, Inc.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aldagen, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Aldagen, Inc.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Aldagen, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Aldagen, Inc.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Aldagen, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Aldagen, Inc.'s Emissions with Industry Peers

Vericel Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 17 hours ago

BioRestorative Therapies, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Regenerative Sciences, Inc.

US
•
Insurance and pension funding services, except compulsory social security services (66)
Updated 2 months ago

XCell-Center

DE
Updated 12 days ago

Lineage Cell Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Celgene Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy